机译:REV3L使人胶质瘤对顺铂具有化学耐药性:其RNAi在协同治疗中的潜力
Department of Neurological Surgery, Brain Tumor Research Center, First Affiliated Hospital, Harbin Medical University, Harbin China State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China;
Department of Neurological Surgery, Brain Tumor Research Center, First Affiliated Hospital, Harbin Medical University, Harbin China;
Department of Neurological Surgery, Brain Tumor Research Center, First Affiliated Hospital, Harbin Medical University, Harbin China;
Department of Neurological Surgery, Shanghai 6th People Hospital, Shanghai Jiao Tong University, Shanghai China;
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai China State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China;
Department of Neurological Surgery, Brain Tumor Research Center, First Affiliated Hospital, Harbin Medical University, Harbin China Department of Neurological Surgery, Brain Tumor Research Center, First Affiliated Hospital, Harbin Medical University, 23 Youzhen St., Harbin 150001, China;
chemoresistance; cisplatin; glioma; REV3L; RNAi;
机译:MicroRNA-93促进人神经胶质瘤细胞的恶性表型并诱导其对替莫唑胺的化学耐药性MicroRNA-93促进人神经胶质瘤细胞的恶性表型并诱导其对替莫唑胺的化学抗性MicroRNA-93促进人胶质瘤细胞的恶性表型并诱导其对胶质瘤细胞的恶性表型。替莫唑胺
机译:MicroRNA-93促进人神经胶质瘤细胞的恶性表型并诱导其对替莫唑胺的化学耐药性MicroRNA-93促进人神经胶质瘤细胞的恶性表型并诱导其对替莫唑胺的化学抗性MicroRNA-93促进人胶质瘤细胞的恶性表型并诱导其对胶质瘤细胞的恶性表型。替莫唑胺
机译:圆形RNA PRMT5通过MIR-4458 / Rev3L轴在非小细胞肺癌中赋予顺铂抗性
机译:S-硝基吡咯肠和缺氧诱导因子-1赋予大鼠C6胶质瘤细胞中BCNU的碳酸化细胞毒性的化学抑制性
机译:人类恶性神经胶质瘤中化学抗性的基因表达谱。
机译:REV3L使人胶质瘤对顺铂具有化学耐药性:其RNAi在协同治疗中的潜力
机译:REV3L使人胶质瘤对顺铂具有化学耐药性:其RNAi在协同治疗中的潜力
机译:在人体中使用苦马豆素与高剂量化疗的潜在用途的临床前研究:化学保护和改善特性